Synphatec
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- Undisclosed
Investors
- 6
About Synphatec
, trading as Synphatec, focuses on research and development of novel treatments for central nervous system disorders. The company focuses on advancing its pipeline of preclinical and early-stage clinical programs targeting psychiatric and neurodegenerative diseases such as depression and Alzheimer's disease. The company's revenue is generated by providing novel treatments for central nervous system disorders.
Who invested in Synphatec
6 investors across 1 round
See all investors in Synphatec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 28, 2026
Amount
Undisclosed
Investors
Questions about Synphatec
Who invested in Synphatec?
Synphatec has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synphatec raised?
Synphatec has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Synphatec last raise money?
Synphatec's most recent round on record is a Series A, in Sep 2026.
What does Synphatec do?
, trading as Synphatec, focuses on research and development of novel treatments for central nervous system disorders.
Where is Synphatec headquartered?
Synphatec is headquartered in Shanghai, China.
Which VCs invest in companies like Synphatec?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Synphatec's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Synphatec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.